Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
Summary: As the number of global deaths attributed to cardiovascular disease continues to rise, viable treatments for cardiovascular events such as myocardial infarction or conditions like peripheral artery disease are critical. Recent studies investigating injectable biomaterials have shown promise...
Main Authors: | Melissa J. Hernandez, BS, Karen L. Christman, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-04-01
|
Series: | JACC: Basic to Translational Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X17300426 |
Similar Items
-
Biomaterials for Injectable Therapeutic Implants
by: Olivier Jordan, et al.
Published: (2005-06-01) -
Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials
by: Vishnu Vasanthan, et al.
Published: (2020-04-01) -
Therapeutics That Promote Sympathetic Reinnervation Modulate the Inflammatory Response After Myocardial Infarction
by: Joseph J. Sepe, PhD, et al.
Published: (2022-09-01) -
Myocardial infarction impaired wall mechanics and hemodynamics in peripheral arteries
by: Qiang Xue, et al.
Published: (2023-08-01) -
Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction
by: Xiaoping Zhang, et al.
Published: (2022-07-01)